Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical Genetics

Confirming the Diagnosis: Tests and Procedures

At a Glance

Kearns-Sayre syndrome (KSS) is diagnosed by finding large-scale mitochondrial DNA deletions, often requiring a muscle biopsy if blood tests are negative. A complete diagnostic workup also includes checking spinal fluid and performing baseline screenings for the heart, eyes, and endocrine system.

The journey to a Kearns-Sayre Syndrome (KSS) diagnosis often involves several different types of tests. Because KSS is a multisystem disorder, doctors use a combination of genetic testing, biochemical markers, and clinical exams to confirm the diagnosis and establish a baseline for your care [1][2].

The Genetic “Gold Standard”

The definitive way to confirm KSS is to find a large-scale deletion in your mitochondrial DNA (mtDNA) [3][4].

The Blood vs. Muscle Dilemma

One of the most confusing parts of the KSS diagnosis is that a blood test may come back “normal” even if you have the disease. This happens because of tissue heteroplasmy [3].

  • Blood cells divide very quickly. Over time, the body may naturally “select” against the deleted mitochondria in the blood, making them disappear from your circulation [3].
  • Muscle cells do not divide quickly. Therefore, the deleted mitochondria stay in the muscle tissue for your entire life [3][5].

If your doctor strongly suspects KSS but your blood work is negative, a muscle biopsy is often the next step to find the deletion and look for “ragged red fibers”—a classic sign of mitochondrial damage under the microscope [5][6].

Supportive “Clues” in the Body

While genetic testing provides the “final answer,” other tests help build the case for KSS:

  • Cerebrospinal Fluid (CSF) Protein: A lumbar puncture (spinal tap) often shows very high protein levels in KSS, frequently above 100 mg/dL [7][8]. This is a hallmark supportive finding that helps doctors rule out other neurological conditions [2].
  • Cerebrospinal Fluid (CSF) Folate: Recent research has shown that KSS patients often have low levels of 5-MTHF (a form of folate) in their spinal fluid, which can contribute to neurological decline if left untreated [9][10].
  • Brain MRI: Imaging of the brain often shows specific patterns, such as leukodystrophy (changes in the brain’s white matter) or cerebellar atrophy (shrinking of the balance center of the brain) [11][12].

Your Diagnostic Checklist

A full workup for KSS is about more than just getting a name for the condition; it is about ensuring every part of your body is safe. Ensure your medical team has completed the following baseline evaluations:

  • [ ] Genetic Testing: Using Next-Generation Sequencing (NGS) to look for large-scale mtDNA deletions in blood or muscle [4][6].
  • [ ] Cardiac Screening: An EKG and a Holter monitor (a 24-hour heart rhythm recording) to check for life-threatening heart block [13][14].
  • [ ] Ophthalmology Exam: A dilated eye exam to check for pigmentary retinopathy [15][1].
  • [ ] Hearing Test: An audiometry exam to check for sensorineural hearing loss [16][2].
  • [ ] Endocrine Labs: Blood tests to check for diabetes, hypoparathyroidism (calcium regulation), and growth hormone levels [17][18].
  • [ ] Neurology Baseline: An assessment of balance and coordination (ataxia) and a brain MRI [12][8].
  • [ ] Lumbar Puncture: Measuring CSF protein and importantly, CSF folate (5-MTHF) levels to detect cerebral folate deficiency [8][9].

Having these baseline results is vital because they allow your doctors to monitor for any changes over time and intervene early when needed [19][20].

Common questions in this guide

Why might my KSS genetic blood test be negative if I have the condition?
Blood cells divide quickly, and over time, your body can naturally clear out the cells with damaged mitochondrial DNA. Because of this, a blood test may look normal, requiring a muscle biopsy to confirm the diagnosis since muscle cells hold onto the damaged mitochondria.
What is the purpose of a muscle biopsy for Kearns-Sayre syndrome?
A muscle biopsy is used to look for large-scale deletions in your mitochondrial DNA when blood tests are inconclusive. Under a microscope, pathologists also look for "ragged red fibers," which are a classic sign of mitochondrial damage in KSS.
Why do doctors perform a lumbar puncture (spinal tap) when diagnosing KSS?
A spinal tap checks for elevated protein levels in your cerebrospinal fluid, which is a hallmark sign of Kearns-Sayre syndrome. Doctors also check for low folate levels in the spinal fluid, which can cause neurological issues if not treated.
What baseline tests are needed after a Kearns-Sayre syndrome diagnosis?
A complete baseline workup should include an EKG and Holter monitor for your heart, a dilated eye exam, an audiometry test for hearing, a brain MRI, and blood tests to check your endocrine function. These tests establish a baseline so doctors can monitor for any changes over time.

Get notified when new evidence is published on Kearns-Sayre syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    A rare case of Kearns-Sayre syndrome in a 17-year-old Venezuelan male with bilateral ptosis as the initial presentation.

    Leal M, Dhoble C, Lee J, et al.

    Oxford medical case reports 2016; (2016(3)):34-6 doi:10.1093/omcr/omw007.

    PMID: 26949540
  2. 2

    Unusual Phenotype and Disease Trajectory in Kearns-Sayre Syndrome.

    Finsterer J, Winklehner M, Stöllberger C, Hummel T

    Case reports in neurological medicine 2020; (2020()):7368527 doi:10.1155/2020/7368527.

    PMID: 32181031
  3. 3

    Ophthalmoplegia in Mitochondrial Disease.

    Lee SJ, Na JH, Han J, Lee YM

    Yonsei medical journal 2018; (59(10)):1190-1196 doi:10.3349/ymj.2018.59.10.1190.

    PMID: 30450853
  4. 4

    Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with Kearns-Sayre Syndrome.

    Guo L, Wang X, Ji H

    DNA and cell biology 2020; (39(8)):1449-1457 doi:10.1089/dna.2019.5010.

    PMID: 32609007
  5. 5

    Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and Literature Review.

    Moustaine MO, Azemour Z, Mohammed F, et al.

    Archives of plastic surgery 2024; (51(2)):182-186 doi:10.1055/a-2207-7587.

    PMID: 38596148
  6. 6

    Expanding the Genetic and Phenotypic Spectrum of Kearns-Sayre Syndrome: A Case Report.

    Messina C

    Cureus 2025; (17(5)):e84293 doi:10.7759/cureus.84293.

    PMID: 40524992
  7. 7

    Exophthalmos in Kearns-Sayre syndrome.

    Tauber J, Polla DJ, Park S

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2019; (23(5)):295-297 doi:10.1016/j.jaapos.2019.05.005.

    PMID: 31158487
  8. 8

    Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation.

    Zhao H, Shi M, Yang F, Yang X

    Neurosciences (Riyadh, Saudi Arabia) 2022; (27(2)):111-115 doi:10.17712/nsj.2022.2.20210123.

    PMID: 35477912
  9. 9

    Kearns-Sayre syndrome presenting with fanconi syndrome: a case report.

    Lu Y, Jian S, Qian M, et al.

    Translational pediatrics 2025; (14(5)):1059-1064 doi:10.21037/tp-2025-138.

    PMID: 40519735
  10. 10

    Increased Sphingomyelin and Free Sialic Acid in Cerebrospinal Fluid of Kearns-Sayre Syndrome: New Findings Using Untargeted Metabolomics.

    Salvador CL, Oppebøen M, Vassli AØ, et al.

    Pediatric neurology 2023; (143()):68-76 doi:10.1016/j.pediatrneurol.2023.02.016.

    PMID: 37018879
  11. 11

    Kearns-Sayre syndrome: expanding spectrum of a "novel" mitochondrial leukomyeloencephalopathy.

    Moscatelli M, Ardissone A, Lamantea E, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):2081-2084 doi:10.1007/s10072-022-05881-8.

    PMID: 35031921
  12. 12

    Kearns-Sayre syndrome with restricted diffusion in subcortical white matter and extraocular muscle atrophy.

    Matsukawa M, Maeda M, Tanaka F, et al.

    Radiology case reports 2025; (20(6)):2646-2650 doi:10.1016/j.radcr.2025.02.088.

    PMID: 40151283
  13. 13

    Progressive Conduction Disease in a Mitochondrial Disorder.

    Amaro T, Bueno S, Guirão C, et al.

    JACC. Case reports 2026; 107749 doi:10.1016/j.jaccas.2026.107749.

    PMID: 42171571
  14. 14

    Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome.

    Trivedi M, Goldstein A, Arora G

    Cardiology in the young 2018; (28(12)):1487-1488 doi:10.1017/S1047951118001609.

    PMID: 30326976
  15. 15

    Teaching NeuroImages: Kearns-Sayre syndrome.

    Nguyen MTB, Micieli J, Margolin E

    Neurology 2019; (92(5)):e519-e520 doi:10.1212/WNL.0000000000006861.

    PMID: 30635486
  16. 16

    Should Patients with Kearns-Sayre Syndrome and Corneal Endothelial Failure Be Genotyped for a TCF4 Trinucleotide Repeat, Commonly Associated with Fuchs Endothelial Corneal Dystrophy?

    Dudakova L, Skalicka P, Davidson AE, et al.

    Genes 2021; (12(12)) doi:10.3390/genes12121918.

    PMID: 34946867
  17. 17

    Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review.

    Zhang J, Song Z, Zhou H, et al.

    Frontiers in medicine 2025; (12()):1575384 doi:10.3389/fmed.2025.1575384.

    PMID: 40823579
  18. 18

    A case of hypopituitarism accompanying Kearns-Sayre syndrome treated with human chorionic gonadotropin: A case report and literature review.

    Kang YX, Wang YJ, Zhang Q, et al.

    Andrologia 2017; (49(8)) doi:10.1111/and.12711.

    PMID: 27709644
  19. 19

    Kearns-Sayre syndrome presenting with progressive external ophthalmoplegia and third-degree atrioventricular block diagnostic challenge in resource-limited settings: a case report.

    Azibte GT, Ayalew ZS, Molla BA, et al.

    Journal of medical case reports 2025; (19(1)):127 doi:10.1186/s13256-025-05086-5.

    PMID: 40114248
  20. 20

    Kearns-Sayre syndrome: Two case reports and a review for the primary care physician.

    Richmond C, Powell L, Brittingham ZD, Mancuso A

    Journal of family medicine and primary care 2023; (12(4)):792-795 doi:10.4103/jfmpc.jfmpc_1790_22.

    PMID: 37312792

This page provides educational information about diagnostic testing for Kearns-Sayre Syndrome. It is not a substitute for professional medical advice, diagnosis, or evaluation by a neuromuscular specialist or geneticist.